{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T19:34:02Z","timestamp":1779910442495,"version":"3.53.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,2,7]],"date-time":"2017-02-07T00:00:00Z","timestamp":1486425600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Headache Pain"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s10194-016-0717-7","type":"journal-article","created":{"date-parts":[[2017,2,7]],"date-time":"2017-02-07T15:13:50Z","timestamp":1486480430000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Randomized, double-blind, crossover study comparing DFN-11 injection (3\u00a0mg subcutaneous sumatriptan) with 6\u00a0mg subcutaneous sumatriptan for the treatment of rapidly-escalating attacks of episodic migraine"],"prefix":"10.1186","volume":"18","author":[{"given":"Roger K.","family":"Cady","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sagar","family":"Munjal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan J.","family":"Cady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather R.","family":"Manley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elimor","family":"Brand-Schieber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,2,7]]},"reference":[{"key":"717_CR1","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1177\/0333102413485658","volume":"33","author":"Headache Classification Committee of the International Headache Society (IHS)","year":"2013","unstructured":"Headache Classification Committee of the International Headache Society (IHS) (2013) The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 33:629\u2013808","journal-title":"Cephalalgia"},{"key":"717_CR2","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1517\/14656566.2012.730041","volume":"13","author":"L Lionetto","year":"2012","unstructured":"Lionetto L, Negro A, Casolla B et al (2012) Sumatriptan succinate: pharmacokinetics of different formulations in clinical practice. Expert Opin Pharmacother 13:2369\u20132380","journal-title":"Expert Opin Pharmacother"},{"key":"717_CR3","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1212\/01.wnl.0000252808.97649.21","volume":"68","author":"RB Lipton","year":"2007","unstructured":"Lipton RB, Bigal ME, Diamond M et al (2007) Migraine prevalence, disease burden, and the need for preventive therapy. Neurology 68:343\u2013349","journal-title":"Neurology"},{"key":"717_CR4","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1001\/jama.1992.03480010072027","volume":"267","author":"WF Stewart","year":"1992","unstructured":"Stewart WF, Lipton RB, Celentano DD et al (1992) Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors. JAMA 267:64\u201369","journal-title":"JAMA"},{"key":"717_CR5","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1046\/j.1526-4610.2001.041007646.x","volume":"41","author":"RB Lipton","year":"2001","unstructured":"Lipton RB, Stewart WF, Diamond S et al (2001) Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache 41:646\u2013657","journal-title":"Headache"},{"key":"717_CR6","unstructured":"World Health Organization. Global Health Estimates 2014 summary tables. YLD Global 2000\u20132012, June 2014. Available at: http:\/\/www.who.int\/entity\/healthinfo\/global_burden_disease\/GHE_YLD_Global_2000_2012.xls?ua=1.http:\/\/www.who.int\/entity\/healthinfo\/global_burden_disease\/GHE_YLD_Global_2000_2012.xls?ua=1 . Accessed 3 Dec 2016."},{"key":"717_CR7","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1742-1241.2003.tb10540.x","volume":"57","author":"AJ Dowson","year":"2003","unstructured":"Dowson AJ, Sender J, Lipscombe S et al (2003) Establishing principles for migraine management in primary care. Int J Clin Pract 57:493\u2013507","journal-title":"Int J Clin Pract"},{"key":"717_CR8","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1016\/S0140-6736(01)06711-3","volume":"358","author":"MD Ferrari","year":"2001","unstructured":"Ferrari MD, Roon KI, Lipton RB et al (2001) Oral triptans (serotonin 5-HT(1B\/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials. Lancet 358:1668\u20131675","journal-title":"Lancet"},{"key":"717_CR9","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1517\/14656566.2014.858120","volume":"15","author":"F Napoletano","year":"2014","unstructured":"Napoletano F, Lionetto L, Martelletti P (2014) Sumatriptan in clinical practice: effectiveness in migraine and the problem of psychiatric comorbidity. Expert Opin Pharmacother 15:303\u2013305","journal-title":"Expert Opin Pharmacother"},{"key":"717_CR10","doi-asserted-by":"publisher","first-page":"2831","DOI":"10.1001\/jama.1991.03460210077033","volume":"265","author":"RK Cady","year":"1991","unstructured":"Cady RK, Wendt JK, Kirchner JR et al (1991) Treatment of acute migraine with subcutaneous sumatriptan. JAMA 265:2831\u20132835","journal-title":"JAMA"},{"key":"717_CR11","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1056\/NEJM199108013250504","volume":"325","author":"The Subcutaneous Sumatriptan International Study Group","year":"1991","unstructured":"The Subcutaneous Sumatriptan International Study Group (1991) Treatment of migraine attacks with sumatriptan. N Engl J Med 325:316\u2013321","journal-title":"N Engl J Med"},{"key":"717_CR12","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1185\/03007995.2012.674501","volume":"28","author":"K Erlichson","year":"2012","unstructured":"Erlichson K, Waight J (2012) Therapeutic applications for subcutaneous triptans in the acute treatment of migraine. Curr Med Res Opin 28:1231\u20131238","journal-title":"Curr Med Res Opin"},{"key":"717_CR13","unstructured":"IMITREX (sumatriptan succinate) Injection prescribing information. Available at: https:\/\/www.gsksource.com\/pharma\/content\/dam\/GlaxoSmithKline\/US\/en\/Prescribing_Information\/Imitrex_Injection\/pdf\/IMITREX-INJECTION-PI-PPI.PDF . Accessed 3 Dec 2016."},{"key":"717_CR14","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1001\/archneur.1992.00530360073020","volume":"49","author":"NT Mathew","year":"1992","unstructured":"Mathew NT, Dexter J, Couch J et al (1992) Dose ranging efficacy and safety of subcutaneous sumatriptan in the acute treatment of migraine. US Sumatriptan Research Group. Arch Neurol 49:1271\u20131276","journal-title":"Arch Neurol"},{"key":"717_CR15","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1046\/j.1526-4610.2003.03006.x","volume":"43","author":"RM Gallagher","year":"2003","unstructured":"Gallagher RM, Kunkel R (2003) Migraine medication attributes important for patient compliance: concerns about side effects may delay treatment. Headache 43:36\u201343","journal-title":"Headache"},{"key":"717_CR16","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1056\/NEJMra010917","volume":"346","author":"PJ Goadsby","year":"2002","unstructured":"Goadsby PJ, Lipton RB, Ferrari MD (2002) Migraine--current understanding and treatment. N Engl J Med 346:257\u2013270","journal-title":"N Engl J Med"},{"issue":"Suppl 3","key":"717_CR17","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1185\/030079905X46269","volume":"21","author":"A Gendolla","year":"2005","unstructured":"Gendolla A (2005) Part I: what do patients really need and want from migraine treatment? Curr Med Res Opin 21(Suppl 3):S3\u2013S7","journal-title":"Curr Med Res Opin"},{"issue":"Suppl 1","key":"717_CR18","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1046\/j.1526-4610.2002.0420s1003.x","volume":"42","author":"RB Lipton","year":"2002","unstructured":"Lipton RB, Hamelsky SW, Dayno JM (2002) What do patients with migraine want from acute migraine treatment? Headache 42(Suppl 1):3\u20139","journal-title":"Headache"},{"key":"717_CR19","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1016\/j.clinthera.2006.10.011","volume":"28","author":"P Winner","year":"2006","unstructured":"Winner P, Adelman J, Aurora S et al (2006) Efficacy and tolerability of sumatriptan injection for the treatment of morning migraine: two multicenter, prospective, randomized, double-blind, controlled studies in adults. Clin Ther 28:1582\u20131591","journal-title":"Clin Ther"},{"key":"717_CR20","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1111\/j.1526-4610.2005.05072.x","volume":"45","author":"SH Landy","year":"2005","unstructured":"Landy SH, Mcginnis JE, Mcdonald SA (2005) Pilot study evaluating preference for 3-mg versus 6-mg subcutaneous sumatriptan. Headache 45:346\u2013349","journal-title":"Headache"},{"key":"717_CR21","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1046\/j.1468-2982.1996.1608554.x","volume":"16","author":"WH Visser","year":"1996","unstructured":"Visser WH, Jaspers NM, De Vriend RH et al (1996) Chest symptoms after sumatriptan: a two-year clinical practice review in 735 consecutive migraine patients. Cephalalgia 16:554\u2013559","journal-title":"Cephalalgia"},{"issue":"Suppl 1","key":"717_CR22","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1046\/j.1526-4610.2002.0420s1038.x","volume":"42","author":"JT Wang","year":"2002","unstructured":"Wang JT, Barr CE, Goldfarb SD (2002) Impact of chest pain on cost of migraine treatment with almotriptan and sumatriptan. Headache 42(Suppl 1):38\u201343","journal-title":"Headache"},{"key":"717_CR23","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1002\/ana.10785","volume":"55","author":"R Burstein","year":"2004","unstructured":"Burstein R, Jakubowski M (2004) Analgesic triptan action in an animal model of intracranial pain: a race against the development of central sensitization. Ann Neurol 55:27\u201336","journal-title":"Ann Neurol"},{"key":"717_CR24","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/S0149-2918(00)80083-1","volume":"22","author":"RK Cady","year":"2000","unstructured":"Cady RK, Sheftell F, Lipton RB et al (2000) Effect of early intervention with sumatriptan on migraine pain: retrospective analyses of data from three clinical trials. Clin Ther 22:1035\u20131048","journal-title":"Clin Ther"},{"key":"717_CR25","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.4065\/78.10.1214","volume":"78","author":"P Winner","year":"2003","unstructured":"Winner P, Mannix LK, Putnam DG et al (2003) Pain-free results with sumatriptan taken at the first sign of migraine pain: 2 randomized, double-blind, placebo-controlled studies. Mayo Clin Proc 78:1214\u20131222","journal-title":"Mayo Clin Proc"},{"key":"717_CR26","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1046\/j.1526-4610.2000.00144.x","volume":"40","author":"RK Cady","year":"2000","unstructured":"Cady RK, Lipton RB, Hall C et al (2000) Treatment of mild headache in disabled migraine sufferers: results of the Spectrum Study. Headache 40:792\u2013797","journal-title":"Headache"}],"container-title":["The Journal of Headache and Pain"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s10194-016-0717-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-016-0717-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-016-0717-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T03:53:08Z","timestamp":1692676388000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejournalofheadacheandpain.biomedcentral.com\/articles\/10.1186\/s10194-016-0717-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,7]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["717"],"URL":"https:\/\/doi.org\/10.1186\/s10194-016-0717-7","relation":{},"ISSN":["1129-2369","1129-2377"],"issn-type":[{"value":"1129-2369","type":"print"},{"value":"1129-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,7]]},"article-number":"17"}}